4-氨基-2-氯三氟甲苯 | 445-13-6

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟甲苯系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氨基-2-氯三氟甲苯
• 中文别名: 3-氯-4-(三氟甲基)苯胺；3-氯-4-三氟甲基苯胺； 3-氯-4-(三氟甲基)苯胺
• 英文名称: 3-chloro-4-(trifluoromethyl)aniline
• 英文别名: 3-Chloro-4-trifluoromethyl-phenylamine
• CAS: 445-13-6
• 化学式: C₇H₅ClF₃N
• mdl: MFCD00278479
• 分子量: 195.572
• InChiKey: KZAMRRANXJVDCD-UHFFFAOYSA-N

物化性质

• 沸点：
  112-115 °C
• 密度：
  1.425±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22
• 海关编码：
  2921420090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H317,H319
• 储存条件：
  | 室温 |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Chloro-4-trifluoromethylaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H331: Toxic if inhaled
H302: Harmful if swallowed
H312: Harmful in contact with skin
H315: Causes skin irritation
H319: Causes serious eye irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P304+P340:
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Chloro-4-trifluoromethylaniline
CAS number: 445-13-6

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H5ClF3N
Molecular weight: 195.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2810 Class: 6.1 Packing group: III
Proper shipping name: TOXIC, LIQUIDS, ORGANIC, N.O.S. OR TOXIC, LIQUIDS, ORGANIC, N.O.S. INHALA-
TION HAZARD, PACKING GROUP I, ZONE A OR B (3-Chloro-4-trifluoromethylaniline)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用

4-氨基-2-氯三氟甲苯是一种医药中间体。它可通过以下步骤制备：首先由1-溴-2-氯-4-硝基苯为原料制备2-氯-4-硝基-1-三氟甲基苯，然后还原硝基得到目标化合物。

制备 步骤A、2-氯-4-硝基-1-三氟甲基苯的制备

将1-溴-2-氯-4-硝基苯（1.86g，7.86mmol）和CuI（0.225g，1.18mmol）溶解在无水N,N-二甲基甲酰胺（DMF）中，并用氮气脱气15分钟。加入氟磺酰基二氟乙酸甲酯（3.53g，23.6mmol），将混合物加热至80℃，反应16小时后冷却至室温。随后在乙酸乙酯和盐水之间分配反应混合物，并用另外的乙酸乙酯萃取水层。合并有机相，用3×200mL盐水洗涤，用无水硫酸钠干燥，浓缩并经色谱纯化，用乙酸乙酯/己烷（1:9）洗脱。

步骤B、4-氨基-2-氯三氟甲苯的制备

在室温下，将氯化锡(II)二水合物（4.97mmol）一次性加入2-氯-4-硝基-1-三氟甲基苯（4.14mmol）的甲醇溶液中，并搅拌反应16小时。真空浓缩后通过色谱纯化，用乙酸乙酯/己烷（1:4至2:3）洗脱，得到目标化合物。

反应信息

• 作为反应物：
  描述：

  4-氨基-2-氯三氟甲苯 在 硫酸 、 水 、 sodium nitrite 作用下， 反应 3.0h， 以48%的产率得到3-氯-4-三氟甲基苯酚
  参考文献：
  名称：

  Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds as VR1 receptor agonists

  摘要：

  这项发明提供了一种化合物，其化学式为（I）：其中R1代表（C1-C6）烷基基团；R2代表氢原子、卤原子、羟基、（C1-C6）烷基基团或（C1-C6）氧烷基基团；R3、R4、R5和R6分别独立地代表氢原子、（C1-C6）烷基或卤原子；R7代表氢原子、卤原子、羟基、（C1-C6）烷基基团，可选地取代有哌啶基团的（C1-C6）烷基基团，可选地取代有3-7个成员的环烷基环的（C-1-C6）氧烷基基团，羟基（C1-C6）氧烷基基团，（C1-C6）氧烷基（C1-C6）烷基基团，（C1-C6）氧烷基（C1-C6）氧烷基基团，卤代（C1-C6）烷基基团，（C1-C6）烷基硫基基团，（C1-C6）烷基亚硫基基团或（C1-C6）烷基砜基基团；R8代表（C1-C6）烷基基团，卤代（C1-C6）烷基基团，（C1-C6）氧烷基基团，羟基（C1-C6）氧烷基基团，（C1-C6）氧烷基（C1-C6）烷基基团或（C1-C6）氧烷基（C1-C6）氧烷基基团；或者R7和R8，当相邻时，与它们连接的碳原子一起形成一个5-8成员的脂环或杂环环，其中脂环或杂环环未取代或取代有一个或多个选自羟基、（C1-C6）烷基、（C1-C6）氧烷基和羟基（C1-C6）烷基的取代基；R9代表氢原子或卤原子；或其药学上可接受的盐或溶剂。这些化合物可用于治疗由VR1受体过度激活引起的疾病症状，如哺乳动物中的疼痛等。本发明还提供了一种包含化合物（I）的药物组成物。

  公开号：

  US20060100460A1
• 作为产物：
  描述：

  氯化重氮苯 生成 4-氨基-2-氯三氟甲苯
  参考文献：
  名称：

  Combating fungi with dicarboxylic acid mono-arylhydrazides

  摘要：

  用式为##STR1##的二羧酸单芳基肼化合物来对抗真菌，其中R.sup.1和R.sup.2各自独立地是氢、卤素、C.sub.1-C.sub.4烷基、C.sub.1-C.sub.4烷氧基、C.sub.1-C.sub.4烷硫基、三卤甲基、三卤甲氧基、三卤甲硫基或硝基，X是烷基、烯基、环烷基、环烯基、环烷二烯基或苯基基团，M是氢或等效的金属离子，或其盐。

  公开号：

  US04162329A1

文献信息

• [EN] SUBSTITUTED PYRROLES AND METHODS OF USE<br/>[FR] PYRROLES SUBSTITUÉS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：GENENTECH INC

  公开号：WO2009151599A1

  公开（公告）日：2009-12-17

  The invention relates to substituted pyrrole compounds of Formula (I) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chkl) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

  这项发明涉及一种通式（I）的取代吡咯烷化合物，其作为激酶抑制剂有用，更具体地作为检查点激酶1（chkl）抑制剂有用，因此作为癌症治疗药物有用。该发明还涉及包含这些化合物的组合物，更具体地包括这些化合物的药物组合物以及使用它们治疗各种癌症和高增殖性疾病的方法，以及使用这些化合物进行体外、体内和体内诊断或治疗哺乳动物细胞或相关病理条件的方法。
• 吲哚类化合物及其制备方法、药物组合物和用途
  申请人：中国医学科学院药物研究所

  公开号：CN110483366B

  公开（公告）日：2022-09-16

  本发明公开了一类吲哚类化合物及其制备方法、药物组合物和用途，具体而言，本发明涉及通式I所示的吲哚类衍生物及其可药用盐，及其制备方法，含有一个或多个该类化合物的组合物，和该类化合物在制备、预防和/或治疗与IDO1和/或TDO相关的疾病药物中的用途。
• Aryl nitrogen-containing bicyclic compounds and methods of use
  申请人：Patel F. Vinod

  公开号：US20070054916A1

  公开（公告）日：2007-03-08

  The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I wherein A 1 , A 2 , A 3 , B, R 1 , R 2 , R 3 and R 4 are defined herein. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of kinase mediated diseases using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention.

  这项发明涉及一类新的化合物，用于预防和治疗蛋白激酶介导的疾病，包括炎症、癌症和相关疾病。这些化合物具有一般的化学式I，其中A1、A2、A3、B、R1、R2、R3和R4在此有定义。因此，该发明还涉及包括该发明的化合物的药物组合物，使用该发明的化合物和组合物预防和治疗激酶介导的疾病的方法，以及用于制备该发明的化合物的中间体和方法。
• PYRIMIDINE COMPOUND, PREPARATION METHOD THEREOF AND MEDICAL USE THEREOF
  申请人：Ancureall Pharmaceutical (Shanghai) Co., Ltd.

  公开号：US20210101881A1

  公开（公告）日：2021-04-08

  The present invention discloses a pyrimidine compound, a preparation method thereof and a medical use thereof. Specifically, the present invention discloses a pyrimidine compound represented by formula (I), pharmaceutically acceptable salts thereof, a preparation method thereof, and a use thereof as a cyclin-dependent kinase 9 (CDK9) inhibitor, particularly for the treatment of cancer. The definition of each group in formula (I) is the same as that in the specification.

  本发明公开了一种嘧啶化合物，其制备方法及医药用途。具体地，本发明公开了一种由式(I)表示的嘧啶化合物，其药学上可接受的盐，其制备方法，以及作为细胞周期依赖性激酶9（CDK9）抑制剂的用途，特别用于癌症治疗。式(I)中每个基团的定义与规范中的相同。
• Synthesis of 1, 2, 4-triazole benzoyl arylamine derivatives and their high antifungal activities
  作者：Yi-Nan Cheng、Zhen-Hua Jiang、Lian-Sheng Sun、Zi-Yang Su、Meng-Meng Zhang、Hong-Lian Li

  DOI：10.1016/j.ejmech.2020.112463

  日期：2020.8

  Two series of novel 1, 2, 4-triazole benzoyl arylamine derivatives were prepared and screened for their activities against three pathogens of Gaeumannomyces graminis var.tritici, Sclerotinia sclerotiorum and Fusarium graminearum using the mycelium growth inhibition method in vitro. The results indicated that most of the synthesized derivatives displayed antifungal activities. Compounds 6c-d and 6f-g

  制备了两个系列的新颖的1、2、4-三唑苯甲酰基芳基胺衍生物，并筛选了它们对三种遗传病菌的活性。小麦，菌核菌和镰刀菌利用体外抑制菌丝生长的方法。结果表明，大多数合成衍生物具有抗真菌活性。化合物6c-d和6f-g对所有三种病原体的EC 50较低。其中，化合物6g表现出最强的抗真菌活性，EC 50值为0.01、0.19和0.12 μ克毫升-1分别。结构与活性的关系表明，苯胺在Pata位上的缩电基团有利于高活性，优选的基团为烷氧基羰基。这些结果表明，化合物6g可以作为开发新型杀真菌剂的先导化合物。